Publications by authors named "Adriano Targa"

Background: Obstructive sleep apnoea (OSA) is the sleep disorder most frequently found in patients with Alzheimer's disease (AD). The intermittent hypoxia (IH) caused by OSA may participate in AD pathogenesis through increase in oxidative damage and inflammation. We aimed to identify inflammatory and redox genes differentially expressed in the blood from AD patients with severe OSA compared with those with nonsevere OSA.

View Article and Find Full Text PDF

Study Objectives: Actigraphy devices are used in sleep medicine. The Actiwatch 2 (Philips Respironics) was an example of a frequently used device in this field. Nevertheless, the discontinuation of this device has led to an increased necessity for the implementation of other available actigraphy methods capable of providing objective information.

View Article and Find Full Text PDF
Article Synopsis
  • Obstructive sleep apnea (OSA) significantly impacts cardiovascular event recurrence in patients with acute coronary syndrome (ACS), particularly in those without prior cardiovascular disease.
  • The study identified two groups based on the severity of OSA and utilized proteomics to analyze plasma proteins, revealing 24 differentially expressed proteins associated with OSA severity.
  • Bioinformatic analysis suggested that these proteins are involved in key molecular pathways related to immune function, cell signaling, and inflammation, linking OSA to adverse cardiovascular outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • * Out of 260 ICU patients, 43.1% displayed poor sleep quality one year later, with longer ICU stays and mechanical ventilation correlating with greater disruptions in circadian rhythms at this follow-up.
  • * Significant links were found between poor sleep quality and anxiety/depression levels, as well as the fragmentation of circadian rhythms and lung function, emphasizing ongoing health challenges for critical survivors.
View Article and Find Full Text PDF

Sleep disturbances are highly prevalent among patients with Parkinson's disease (PD) and often appear from the early-phase disease or prodromal stages. In this chapter, we will discuss the current evidence addressing the links between sleep dysfunctions in PD, focusing most closely on those data from animal and mathematical/computational models, as well as in human-based studies that explore the electrophysiological and molecular mechanisms by which PD and sleep may be intertwined, whether as predictors or consequences of the disease. It is possible to clearly state that leucine-rich repeat kinase 2 gene (LRRK2) is significantly related to alterations in sleep architecture, particularly affecting rapid eye movement (REM) sleep and non-REM sleep, thus impacting sleep quality.

View Article and Find Full Text PDF

Current studies agree on the impact of sleep and circadian rest-activity rhythm alterations in acute respiratory distress syndrome (ARDS) survivors. However, research on the duration of this impact is scarce. In this study, we evaluate the impact of ARDS on the sleep and circadian rest-activity rhythm of COVID-19 survivors twelve months after hospital discharge.

View Article and Find Full Text PDF

Background: Obstructive sleep apnoea (OSA) has a high prevalence in patients with Alzheimer's disease (AD). Both conditions have been shown to be associated with lipid dysregulation. However, the relationship between OSA severity and alterations in lipid metabolism in the brains of patients with AD has yet to be fully elucidated.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how obstructive sleep apnea (OSA) affects Alzheimer's disease (AD) patients by analyzing the impact of different breathing events on sleep structure and cognitive decline.
  • Conducted with 116 mild-moderate AD patients, the study used polysomnography and cerebrospinal fluid analysis to identify links between apnea events and AD markers.
  • Results show that obstructive apneas and hypopneas disrupt sleep patterns, with hypopneas significantly contributing to cognitive decline over a year, emphasizing the need for tailored patient care in managing AD alongside sleep disorders.
View Article and Find Full Text PDF

We characterized the polysomnography (PSG) parameters associated with alterations in the circadian blood pressure (BP) pattern aiming to identify the main contributors to explain the nondipper profile in obstructive sleep apnea (OSA). This is an observational prospective-multicenter study that included participants referred to the sleep unit for suspected OSA. Following a PSG study, subjects with an apnea-hypopnea index (AHI) ≥5 events/hr were included.

View Article and Find Full Text PDF
Article Synopsis
  • Critical COVID-19 survivors have a significant risk of respiratory issues, leading to a study that identifies factors linked to poor lung function and CT scan abnormalities in these patients.
  • The study involved 1,327 patients from 52 Spanish intensive care units, examining their health data at hospital admission and follow-up, which occurred around 3.57 months after discharge.
  • Results showed many patients had reduced lung capacity and CT scans revealed issues like pulmonary infiltrates and fibrosis, with age, chronic lung disease, and mechanical ventilation duration being key predictors of these complications.
View Article and Find Full Text PDF

Parkinson's disease (PD) is characterized by a range of motor signs, but cognitive dysfunction is also observed. Supplementation with folic acid and vitamin B12 is expected to prevent cognitive impairment. To test this in PD, we promoted a lesion within the substantia nigra of rats using the neurotoxin rotenone.

View Article and Find Full Text PDF
Article Synopsis
  • Obstructive sleep apnea (OSA) is common in Alzheimer’s disease (AD) patients and both conditions may affect lipid metabolism, prompting an investigation into lipid differences between AD patients with and without severe OSA.
  • The study involved 103 AD patients, assessed for severe OSA via polysomnography and their blood lipid profiles analyzed with advanced techniques.
  • A specific 4-lipid signature was found that accurately detected severe OSA, enhancing existing screening methods and suggesting a new approach for personalized patient management.
View Article and Find Full Text PDF

Objective: To determine the association between Obstructive Sleep Apnea (OSA) with long-term symptoms and inflammatory cytokines, exploring the changes between 4-months and 1-year after COVID-19 infection.

Methods: We conducted an observational, prospective cohort study, including patients ≥18 years old with confirmed diagnosis of COVID-19 between April to July 2020. All participants underwent two clinical follow-up visits, the first at 4-months (Visit 1) and the second at 1 year, after SARS-CoV-2 infection (Visit 2).

View Article and Find Full Text PDF

Background: The clinical heterogeneity of COVID-19 suggests the existence of different phenotypes with prognostic implications. We aimed to analyze comorbidity patterns in critically ill COVID-19 patients and assess their impact on in-hospital outcomes, response to treatment and sequelae.

Methods: Multicenter prospective/retrospective observational study in intensive care units of 55 Spanish hospitals.

View Article and Find Full Text PDF

Objective: To describe the prevalence and severity of sleep disorders and circadian alterations in COVID-19 patients four months after the acute phase of the disease.

Methods: This was a cross-sectional observational prospective study of patients with mild COVID-19, moderate COVID-19 (requiring hospitalization but no mechanical ventilation), or severe COVID-19 (with ARDS) four months after the acute phase of the disease. All patients underwent a home sleep apnea test and seven-day wrist actigraphy, as well as completing questionnaires to assess sleep quality and mental health.

View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is prevalent in patients with acute coronary syndrome (ACS) and is a cause of secondary hypertension. To explore the long-term effects of OSA and continuous positive airway pressure (CPAP) treatment on blood pressure (BP) in patients with ACS. analysis of the ISAACC study (Continuous Positive Airway Pressure in Patients with Acute Coronary Syndrome and Obstructive Sleep Apnea; NCT01335087) included 1,803 patients admitted for ACS.

View Article and Find Full Text PDF

Stroke is a neurological syndrome resulting from the sudden interruption of blood flow. Among the symptoms/consequences of the stroke are muscle weakness in the lower and/or upper limbs, decreased sensitivity, altered fine motor skills, proprioception, and reflections. The treatment for the motor consequences is orthopedic management, in which the physiotherapist assists the individual in repetitive range of motion exercises, which can be demotivating during the treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * Results indicated that over 60% of participants experienced poor sleep quality, with female patients and those who received invasive mechanical ventilation during their stay being more affected.
  • * The study emphasizes the need to address sleep health and mental well-being in COVID-19 recovery, noting that anxiety and depression are linked to sleep disruptions.
View Article and Find Full Text PDF

Recent studies have evaluated the potential of circulating microRNAs (miRNAs) as valuable biomarkers for characterizing obstructive sleep apnea (OSA) in males. The potential use of miRNAs as clinical indicators in females is unknown. The objective is to identify a set of miRNAs to be used as endogenous controls (ECs) in female patients with OSA.

View Article and Find Full Text PDF